Although this phenotype, broadly termed BRCAness, is most commonly associated with germline mutations in BRCA1/2, evidence from basic and clinical studies suggest that other genetic and epigenetic alterations may have similar effects on cancer risk, tumor molecular features, and drug sensitivity45. Here, BRCA1 is linked to cancer.